🇺🇸 FDA
Pipeline program

PROTAMINE CHOAY 1000 U.A.H./ml, solution injectable

APHP211046

Phase 3 small_molecule active

Quick answer

PROTAMINE CHOAY 1000 U.A.H./ml, solution injectable for Any patients ≥18 years old, eligible for transfemoral TAVI with coverage for medical insurance is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Any patients ≥18 years old, eligible for transfemoral TAVI with coverage for medical insurance
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials